APA (7th ed.) Citation

Huang, Z., Hu, X., Wei, Y., Lai, Y., Qi, J., Pang, J., . . . Cai, P. (2024). ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification. PLoS ONE, 19(5), 1. https://doi.org/10.1371/journal.pone.0303909

Chicago Style (17th ed.) Citation

Huang, Zhe, Xu Hu, Yiqiu Wei, Yousheng Lai, Jiaming Qi, Jinglin Pang, Kang Huang, Huagui Li, and Pengzhu Cai. "ADAMTSL2 Is a Potential Prognostic Biomarker and Immunotherapeutic Target for Colorectal Cancer: Bioinformatic Analysis and Experimental Verification." PLoS ONE 19, no. 5 (2024): 1. https://doi.org/10.1371/journal.pone.0303909.

MLA (9th ed.) Citation

Huang, Zhe, et al. "ADAMTSL2 Is a Potential Prognostic Biomarker and Immunotherapeutic Target for Colorectal Cancer: Bioinformatic Analysis and Experimental Verification." PLoS ONE, vol. 19, no. 5, 2024, p. 1, https://doi.org/10.1371/journal.pone.0303909.